Anne‐Françoise Tilkin‐Mariamé

Author

Also Known As

A F Tilkin-Mariame, A.F. Tilkin-Mariamé, Anne-Francoise Tilkin-Mariamé, Anne-Françoise Tilkin-Mariamé, Anne-Françoise Tilkin–Mariamé, Anne‐Françoise Tilkin‐Mariamé

Publications

483

Citations

H-Index

Concepts

All Affiliations

Inserm Université Toulouse III - Paul Sabatier Centre de Recherche en Cancérologie de Toulouse Institut Claudius Regaud Centre National de la Recherche Scientifique

About

Anne‐Françoise Tilkin‐Mariamé is an author at Inserm specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	236
2	Cell Biology	7	7	236
3	Immunology	6	6	224
4	Pharmacology	1	1	12
5	Autoimmunity	1	1	11

Anne‐Françoise Tilkin‐Mariamé

Publications

452

Citations

H-Index

Page 1

	Year	Citations
Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma Florie Bertrand, Julia Rochotte, Céline Colacios, Cancer Research Adaptive Immune SystemImmunologyImmune RegulationImmunologic MechanismMelanoma Growth	2015	106
Melanoma-expressed CD70 is involved in invasion and metastasis Christine Pich-Bavastro, Guillaume Sarrabayrouse, Iotefa Teiti, British Journal of Cancer	2015	54
Statins Reduce Melanoma Development and Metastasis through MICA Overexpression Christine Pich-Bavastro, Iotefa Teiti, Philippe Rochaix, Frontiers in Immunology InflammationCancer ImmunosurveillanceSkin CancerMedicineMelanoma	2013	47
FAK alternative splice mRNA variants expression pattern in colorectal cancer Christel Devaud, Anne‐Françoise Tilkin‐Mariamé, Alix Vignolle‐Vidoni, International Journal of Cancer	2019	37
Geranylgeranyl transferase inhibition stimulates antimelanoma immune response through MHC class I and costimulatory molecule expression Anne‐Françoise Tilkin‐Mariamé, Carine Cormary, Nathalie Ferro, The FASEB Journal	2005	30
Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules Carine Cormary, Ricardo González, Jean‐Charles Faye, Cancer Gene Therapy Tumor ImmunologyCancer ImmunosurveillanceTumor GrowthT-regulatory CellImmunology	2004	27
Colon-specific immune microenvironment regulates cancer progression versus rejection Giulia Trimaglio, Anne‐Françoise Tilkin‐Mariamé, Virginie Féliu, OncoImmunology	2020	27
Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth Franck Gallardo, Bernard Mariamé, Rémi Gence, Drug Design Development and Therapy	2018	25
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression Iotefa Teiti, Florie Bertrand, Christine Pich-Bavastro, Frontiers in Oncology ImmunologyImmunoeditingImmunotherapeuticsDermatologyImmunotherapy	2015	18
Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells Guillaume Sarrabayrouse, Christine Pich-Bavastro, Raphaël Moriez, PLoS ONE	2010	18

Page 1